Saturday, March 2, 2024


Novo Nordisk

Novo Nordisk Expands Active Pharmaceutical Ingredients Production with $6 Billion Investment to Meet Rising Demand

Novo Nordisk, a global healthcare company, is investing over $6 billion to extend its active pharmaceutical ingredients (API) production capacity in Denmark. The move...

Eli Lilly, Novo Nordisk, Moderna and Regeneron Post Strong Quarterly Earnings Owing to Successful Development Initiatives

Eli Lilly, Novo Nordisk, Moderna, and Regeneron achieved robust quarterly earnings, attributing it to the success of their drug and pipeline development initiatives. Eli...

Latest news

Sticky Image